North America Patient Controlled Injectors Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Patient Controlled Injectors Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Patient Controlled Injectors Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Patient Controlled Injectors Market Regional Analysis

6.2 North America Patient Controlled Injectors Market Revenue 2017-2027 (US$ Million)

6.3 North America Patient Controlled Injectors Market Forecast Analysis

7. North America Patient Controlled Injectors Market Analysis – by Product

7.1 Electronic Injectors

7.1.1 Overview
7.1.2 Electronic Injectors: North America Patient Controlled Injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.2 Mechanical Injectors

7.2.1 Overview
7.2.2 Mechanical Injectors: North America Patient Controlled Injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.3 Infusion Pumps

7.3.1 Overview
7.3.2 Infusion Pumps: North America Patient Controlled Injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. North America Patient Controlled Injectors Market Analysis – by Application

8.1 Cancer Treatment

8.1.1 Overview
8.1.2 Cancer Treatment: North America Patient Controlled Injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.2 Auto-immune Treatment

8.2.1 Overview
8.2.2 Auto-immune Treatment: North America Patient Controlled Injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.3 Blood Disorders Treatment

8.3.1 Overview
8.3.2 Blood Disorders Treatment: North America Patient Controlled Injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. North America Patient Controlled Injectors Market Analysis – by Distribution Channel

9.1 Hospital Pharmacies

9.1.1 Overview
9.1.2 Hospital Pharmacies: North America Patient Controlled Injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.2 Retail Pharmacies

9.2.1 Overview
9.2.2 Retail Pharmacies: North America Patient Controlled Injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.3 Mail Order Pharmacies

9.3.1 Overview
9.3.2 Mail Order Pharmacies: North America Patient Controlled Injectors Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. North America Patient Controlled Injectors Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Patient Controlled Injectors Market Breakdown, by Key Country, 2020 and 2027 (%)
10.2.1.1 North America Patient Controlled Injectors Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Patient Controlled Injectors Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.1.1 US: North America Patient Controlled Injectors Market Breakdown, by Product
10.2.1.1.2 US: North America Patient Controlled Injectors Market Breakdown, by Application
10.2.1.1.3 US: North America Patient Controlled Injectors Market Breakdown, by Distribution Channel

10.2.1.2 Canada: North America Patient Controlled Injectors Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.2.1 Canada: North America Patient Controlled Injectors Market Breakdown, by Product
10.2.1.2.2 Canada: North America Patient Controlled Injectors Market Breakdown, by Application
10.2.1.2.3 Canada: North America Patient Controlled Injectors Market Breakdown, by Distribution Channel

10.2.1.3 Mexico : North America Patient Controlled Injectors Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.3.1 Mexico : North America Patient Controlled Injectors Market Breakdown, by Product
10.2.1.3.2 Mexico : North America Patient Controlled Injectors Market Breakdown, by Application
10.2.1.3.3 Mexico : North America Patient Controlled Injectors Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Johnson and Johnson Services, Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 West Pharmaceutical Services, Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Enable Injections.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 scPharmaceuticals Inc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 United Therapeutics Corporation

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 BD

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Patient Controlled Injectors Market

Analysis by Product (Electronic Injectors, Mechanical Injectors, and Infusion Pumps); Application (Cancer Treatment, Auto-immune Treatment, Blood Disorders Treatment, and Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Mail Order Pharmacies); and Country